Home

Alivus Life Sciences Ltd EPS

Image

Alivus Life Sciences Ltd

NSE: ALIVUS

EPS

₹ 36.05

Last updated on: Feb 04, 2025

Key Highlights

  • The Earning per Share of Alivus Life Sciences Ltd is ₹ 36.05 as of 04 Feb 25 .
  • The earning per share of Alivus Life Sciences Ltd changed from ₹ 11.05 to ₹ 11.18 over 7 quarters. This represents a CAGR of 0.67% .

Historical Earning per Share of Alivus Life Sciences Ltd

No data available

* All values are in

Company Fundamentals for Alivus Life Sciences Ltd

Market Cap

14,892 Cr

EPS

36.0

P/E Ratio (TTM)

33.7

P/B Ratio (TTM)

5.9

Day’s High

1234.0

Day’s Low

1142.55

DTE

0.0

ROE

16.7

52 Week High

1335.0

52 Week Low

666.05

ROCE

22.3

Market Price of Alivus Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Alivus Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Feb 20251215.4
03 Feb 20251175.05
01 Feb 20251154.6
31 Jan 20251202
30 Jan 20251168.3
29 Jan 20251158.4
28 Jan 20251156.85
27 Jan 20251197.35
24 Jan 20251151.35
23 Jan 20251173.3

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

che

Weakness

2

che

Opportunity

1

che

Threats

0

che

BlinkX Score for Alivus Life Sciences Ltd

Asset Value vs Market Value of Alivus Life Sciences Ltd

Market Value

14,893

Asset Value

Value addition

6.8 X

1,921

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Alivus Life Sciences Ltd14892
Sun Pharmaceuticals Industries Ltd423975
Divis Laboratories Ltd161729
Cipla Ltd116999
Mankind Pharma Ltd105258
Torrent Pharmaceuticals Ltd105084

Historical Market Cap of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical Revenue of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Alivus Life Sciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Alivus Life Sciences Ltd News Hub

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth

Read more

05 Aug 24

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o

Read more

06 Sept 24

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.

Read more

25 Oct 24

Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter

Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe

Read more

25 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Alivus Life Sciences Ltd

What is the EPS of Alivus Life Sciences Ltd stock?

The Earnings Per Share (EPS) of Alivus Life Sciences Ltd is 36.05. An EPS is the amount of net income attributed to each share of a common stock.

How is Alivus Life Sciences Ltd EPS calculated?

The EPS of Alivus Life Sciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Alivus Life Sciences Ltd report its EPS?

Alivus Life Sciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Alivus Life Sciences Ltd EPS?

Factors that influence the EPS of Alivus Life Sciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Alivus Life Sciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Alivus Life Sciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions